Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies

NCT00002608 is registered in ClinicalTrials.gov with Ottawa Regional Cancer Centre as lead sponsor.

NCT NCT00002608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies
Lead sponsor
Ottawa Regional Cancer Centre
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1994
Completion date
April 30, 2005
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenocortical carcinoma, brain and central nervous system tumors, head and neck cancer, liver cancer, malignant mesothelioma, pheochromocytoma, sarcoma